Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Nov 19:12:425.
doi: 10.1186/1475-2875-12-425.

Susceptibility of human Plasmodium knowlesi infections to anti-malarials

Affiliations

Susceptibility of human Plasmodium knowlesi infections to anti-malarials

Farrah A Fatih et al. Malar J. .

Abstract

Background: Evidence suggests that Plasmodium knowlesi malaria in Sarawak, Malaysian Borneo remains zoonotic, meaning anti-malarial drug resistance is unlikely to have developed in the absence of drug selection pressure. Therefore, adequate response to available anti-malarial treatments is assumed.

Methods: Here the ex vivo sensitivity of human P. knowlesi isolates in Malaysian Borneo were studied, using a WHO schizont maturation assay modified to accommodate the quotidian life cycle of this parasite. The in vitro sensitivities of P. knowlesi H strain adapted from a primate infection to in vitro culture (by measuring the production of Plasmodium lactate dehydrogenase) were also examined together with some assays using Plasmodium falciparum and Plasmodium vivax.

Results: Plasmodium knowlesi is uniformly highly sensitive to artemisinins, variably and moderately sensitive to chloroquine, and less sensitive to mefloquine.

Conclusions: Taken together with reports of clinical failures when P. knowlesi is treated with mefloquine, the data suggest that caution is required if using mefloquine in prevention or treatment of P. knowlesi infections, until further studies are undertaken.

PubMed Disclaimer

Figures

Figure 1
Figure 1
IC50 values for anti-malarial drugs against Plasmodium isolates, using the schizont maturation assay. Data points represent mean IC50 values (nM) derived from single experiments performed in triplicate. Plasmodium knowlesi (black symbols), P. vivax (red symbols) and P. falciparum (green symbols). Filled symbols indicate R2 values ≥ 0.8, with unfilled symbols indicting R2 values < 0.8. Mefloquine, MQ; Chloroquine, CQ; Artemisinin, AR; Artemether, AM; Artesunate, AS; Dihydroartemisinin, DHA. Note that there is only mefloquine data for one of the two P. vivax isolates.
Figure 2
Figure 2
Alignment of CRT, ATP6, and MDR1 homologues of P. knowlesi H strain and P. vivax Sal-1 strain, against P. falciparum 3D7 and strains with known point mutations associated with drug resistance. Amino acids are colour coded, with green representing the drug sensitive P. falciparum 3D7, and red representing amino acid changes found in P. falciparum isolates that have a change in drug sensitivity.

References

    1. Singh B, Daneshvar C. Human infections and detection of Plasmodium knowlesi. Clin Microbiol Rev. 2013;26:165–184. - PMC - PubMed
    1. Singh B, Kim Sung L, Matusop A, Radhakrishnan A, Shamsul SS, Cox-Singh J, Thomas A, Conway DJ. A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet. 2004;363:1017–1024. - PubMed
    1. Vythilingam I, Tan CH, Asmad M, Chan ST, Lee KS, Singh B. Natural transmission of Plasmodium knowlesi to humans by Anopheles latens in Sarawak, Malaysia. Trans R Soc Trop Med Hyg. 2006;100:1087–1088. - PubMed
    1. Cox-Singh J, Davis TM, Lee KS, Shamsul SS, Matusop A, Ratnam S, Rahman HA, Conway DJ, Singh B. Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. Clin Infect Dis. 2008;46:165–171. - PMC - PubMed
    1. William T, Rahman HA, Jelip J, Ibrahim MY, Menon J, Grigg MJ, Yeo TW, Anstey NM, Barber BE. Increasing incidence of Plasmodium knowlesi malaria following control of P. falciparum and P. vivax malaria in Sabah, Malaysia. PLoS Negl Trop Dis. 2013;7:e2026. - PMC - PubMed

Publication types

MeSH terms